- Home
- LAB vs GBLI Comparison
LAB vs GBLI Comparison
Compare LAB & GBLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- GBLI
- Stock Information
- Founded
- LAB 1999
- GBLI 2016
- Country
- LAB United States
- GBLI United States
- Employees
- LAB N/A
- GBLI N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- GBLI Property-Casualty Insurers
- Sector
- LAB Industrials
- GBLI Finance
- Exchange
- LAB Nasdaq
- GBLI Nasdaq
- Market Cap
- LAB 473.2M
- GBLI 435.4M
- IPO Year
- LAB 2011
- GBLI 2003
- Fundamental
- Price
- LAB $1.23
- GBLI $29.49
- Analyst Decision
- LAB Buy
- GBLI
- Analyst Count
- LAB 2
- GBLI 0
- Target Price
- LAB $2.50
- GBLI N/A
- AVG Volume (30 Days)
- LAB 1.4M
- GBLI 4.8K
- Earning Date
- LAB 08-11-2025
- GBLI 08-06-2025
- Dividend Yield
- LAB N/A
- GBLI 4.86%
- EPS Growth
- LAB N/A
- GBLI N/A
- EPS
- LAB N/A
- GBLI 1.98
- Revenue
- LAB $172,271,000.00
- GBLI $439,280,000.00
- Revenue This Year
- LAB N/A
- GBLI $7.67
- Revenue Next Year
- LAB $12.18
- GBLI $7.93
- P/E Ratio
- LAB N/A
- GBLI $14.52
- Revenue Growth
- LAB 26.39
- GBLI N/A
- 52 Week Low
- LAB $0.92
- GBLI $26.94
- 52 Week High
- LAB $2.32
- GBLI $37.00
- Technical
- Relative Strength Index (RSI)
- LAB 43.04
- GBLI 46.65
- Support Level
- LAB $1.15
- GBLI $27.82
- Resistance Level
- LAB $1.37
- GBLI $29.59
- Average True Range (ATR)
- LAB 0.07
- GBLI 0.74
- MACD
- LAB -0.02
- GBLI -0.09
- Stochastic Oscillator
- LAB 26.67
- GBLI 56.23
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance world-wide. The company's two segments are: Penn-America and Non-Core Operations. The Penn-America segment offers specialty property and casualty products designed for its Wholesale Commercial, Specialty Products, InsurTech, and Assumed Reinsurance product offerings. These product lines are offered in the excess and surplus lines marketplace; and Non-Core Operations segment contains lines of business that have been de-emphasized or are no longer being written. The majority of its revenue is from the the Penn-America segment . Geographically, the majority is from California.